Pure Global

Drug Test for Direct Bilirubin Quantification - Vietnam Registration 230002524/PCBB-HN

Access comprehensive regulatory information for Drug Test for Direct Bilirubin Quantification in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230002524/PCBB-HN and manufactured by Theo theo phụ lục.

This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Roche Diagnostics GmbH, Roche Diagnostics (Suzhou) Ltd., and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2 Competitors
2 Recent Registrations
230002524/PCBB-HN
Registration Details
Vietnam MOH Registration: 230002524/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug Test for Direct Bilirubin Quantification
VN: Thuốc thử xét nghiệm định lượng bilirubin trực tiếp
Risk Class TTBYT Loại B

Registration Details

230002524/PCBB-HN

000.00.19.H26-230926-0005

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Technical Details

Direct Bilirubin Test is an in vitro diagnostic medical device, used by the professional staff in the colorimetric analysis to quantify the direct bilirubin in human serum and plasma on the Beckman Coulter AU/DxC AU automatic analyzers. The quantitative Direct Bilirubin test is used to support the diagnosis of liver function disorders.

Dates and Status

Oct 05, 2023

Companies Making Similar Products
Companies providing products similar to "Drug Test for Direct Bilirubin Quantification"